Managing experts' conflicts of interest in the EU Joint Clinical Assessment.

ABSTRACT:

Objective

This article critically evaluates the European Commission's 2024 Implementing Regulation (IR) on conflicts of interest (COIs) management for stakeholders in the European Union (EU) Joint Clinical Assessment (JCA), with a focus on individual experts such as clinicians and patient representatives.

Key findings

The IR is the first EU-level framework to assess COIs in the context of health technology assessment (HTA). The regulation requires experts involved in the JCA to submit annual declarations of interest for both financial and non-financial interests and presents a matrix on whether these conflicts should disqualify them from participating in the joint work. We compared the IR to COIs-management approaches from other European national HTA bodies and found that th

SUBMITTER: Gentilini A 

PROVIDER: S-EPMC11574398 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature